跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36 条关于
“ArcStone Kingswood”
全部
36
临床试验
6
药物
3
机构
8
资讯
19
上个月
ArcStone Kingswood Names Karen Sterling, PhD, CFA as Head of Biotechnology Investment Banking
去年
Zhengye Biotechnology Raises $6.9 Million in IPO to Expand Veterinary Vaccine Portfolio
去年
Zhengye Biotechnology Completes $6 Million IPO as Chinese Veterinary Vaccine Manufacturer Enters US Markets
去年
Vertex Pharmaceuticals Drives Growth with Strong Q3 and Pipeline Advances
7个月前
Salspera Files IPO to Fund Phase 3 Trial of Saltikva Bacterial Immunotherapy for Pancreatic Cancer
去年
ARCHIMED Acquires AI-Powered Antimicrobial Stewardship Company Arkstone Medical Group
去年
Avistone's ANS03, a Novel ROS1/NTRK Inhibitor, Receives FDA IND Clearance
去年
Avistone's ANS014004, a Novel c-Met Inhibitor, Advances in Phase I Trials for Solid Tumors
2年前
Avistone's c-MET and EGFR Inhibitor Combination Shows Promise in NSCLC
去年
CStone Pharmaceuticals' CS5001 Demonstrates Promising Activity in Advanced Lymphoma
第 1 页,共 2 页
上一页
下一页